GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AOTI Inc (LSE:AOTI) » Definitions » Current Deferred Revenue

AOTI (LSE:AOTI) Current Deferred Revenue : £0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is AOTI Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

AOTI's current deferred revenue for the quarter that ended in Dec. 2024 was £0.00 Mil.

AOTI Current Deferred Revenue Historical Data

The historical data trend for AOTI's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AOTI Current Deferred Revenue Chart

AOTI Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Current Deferred Revenue
- - - -

AOTI Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24
Current Deferred Revenue Get a 7-Day Free Trial - - - - -

AOTI Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of AOTI's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


AOTI Business Description

Traded in Other Exchanges
N/A
Address
3512 Seagate Way, Suite 100, Oceanside, CA, USA, 92056
AOTI Inc produces, rents, and sells medical devices to help resolve severe acute and chronic wounds for customers globally. The company provides efficacious topical wound oxygen solutions for use in both the institutional and the home care setting to improve the health, well-being, and independence of patients. Its products include TWO2 Extremity Chamber, TWO2 Multi-Patch.

AOTI Headlines

No Headlines